Intensive chemotherapy combined with second- or third-generation tyrosine kinase inhibitors improves survival in patients ...

Researchers sought to elucidate different patterns of disease response in pediatric patients with B-ALL vs T-ALL.

Treatment with cediranib or cediranib plus olaparib is not superior to standard of care (SOC) in patients with platinum-resistant or -refractory epithelial ovarian cancer, according to results from a ...

Researchers sought to determine factors associated with mortality for patients with AML and hyperleukocytosis.

Survey results suggest that cancer patients want financial toxicity screening to occur early, but screening preferences and practices vary.

Although mortality rates are down overall, progress has not been experienced by all women, with racial disparities still seen.

In the years since targeted treatments for CLL were introduced, their use in the second line has increased, but chemotherapy ...

Despite the ongoing debate, study finding support retaining the “cancer” designation for patients with Gleason grade group 1 ...

The overall incidence rates for all cancer sites and specific cancer sites returned to prepandemic levels in 2021, according ...

Survival after moderate HFRT in patients with high-risk prostate cancer was a secondary outcome of the randomized phase 3 Prostate Cancer Study 5 trial.

Researchers sought to determine factors related to complete response in managing LARC with total neoadjuvant therapy.

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...